Multiple Myeloma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
P
Not yet recruiting
  • Multiple Myeloma
  • San Diego, California
  • +2 more
2021-12-01
Dec 1, 2021
N
Not yet recruiting
  • Multiple Myeloma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-12-02
Dec 2, 2021
J
Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +33 more
2021-12-02
Dec 2, 2021
C
Active, not recruiting
  • Multiple Myeloma
  • ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone
  • Atlanta, Georgia
  • +18 more
2021-12-02
Dec 2, 2021
W
Not yet recruiting
  • Multiple Myeloma
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-12-02
Dec 2, 2021
H
Active, not recruiting
  • Multiple Myeloma
  • Lymphoma
  • Washington, District of Columbia
  • +1 more
2021-12-02
Dec 2, 2021
J
Recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +28 more
2021-12-02
Dec 2, 2021
J
Active, not recruiting
  • Multiple Myeloma
  • Dara SC
  • Dara IV
  • Boston, Massachusetts
  • +146 more
2021-12-02
Dec 2, 2021
H
Recruiting
  • Multiple Myeloma
    • Calgary, Alberta, Canada
    • +12 more
    2021-12-02
    Dec 2, 2021
    J
    Recruiting
    • Multiple Myeloma
    • Carfilzomib 20 mg/m^2
    • +4 more
    • Gilbert, Arizona
    • +113 more
    2021-12-02
    Dec 2, 2021
    J
    Active, not recruiting
    • Multiple Myeloma
    • Beijing, China
    • +4 more
    2021-12-02
    Dec 2, 2021
    S
    Recruiting
    • Bone Metastases
    • +4 more
    • Saint Louis, Missouri
      Saint Louis University
    2021-12-02
    Dec 2, 2021